Menu

Fibromyalgia

Fibromyalgia

Complex & Interrelated

Fibromyalgia and Depression are two complex and interrelated conditions that often coexist, sharing several common features. Fibromyalgia is a chronic pain disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and cognitive difficulties. Depression, on the other hand, is a mood disorder characterized by persistent feelings of sadness, loss of interest or pleasure, and changes in appetite and sleep patterns.



Albatross FM Protocol

Our proprietary Physical Therapy and TMS combination therapy is a very novel approach to the treatment of Fibromyalgia-Depression. Application of this holistic approach results in considerable and sustained reduction of symptoms (Musculoskeletal pain and Depression), leading to a much-improved quality of life. 7–8

BOOK APPOINTMENT


Research Backed 

Research has shown a significant association between Fibromyalgia and Depression, with studies indicating that up to 70% of Fibromyalgia patients also experience depressive symptoms. The exact nature of the relationship between these conditions is still not fully understood, but several theories have been proposed. One possibility is that chronic pain and physical limitations associated with Fibromyalgia can contribute to the development of Depression. The constant pain and fatigue can disrupt daily activities, social interactions, and overall quality of life, leading to feelings of hopelessness and despair.1-6

 

 

Impacting Neurotransmitters

 

Neurochemical imbalances in the brain, particularly involving serotonin and other neurotransmitters, have also been implicated in both Fibromyalgia and Depression. Serotonin is a key neurotransmitter involved in regulating mood, sleep, and pain perception, and alterations in its function may contribute to the development of both conditions. Additionally, genetic factors, childhood trauma, and stress have been identified as potential risk factors for both Fibromyalgia and Depression, further highlighting their intertwined nature. 1-6

 

Improve Your Well-Being 

In conclusion, Fibromyalgia and Depression often coexist and share common symptoms, risk factors, and neurochemical abnormalities. The relationship between these conditions is complex and multifaceted, involving both physical and psychological factors. A comprehensive approach to treatment, addressing both the physical and emotional aspects, is crucial for improving the well-being of individuals with Fibromyalgia and Depression.1-6

 

 

 

 

References:

  1.   Wolfe, F., Clauw, D. J., Fitzcharles, M. A., Goldenberg, D. L., Katz, R. S., Mease, P., … & Yunus, M. B. (2010). The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis care & research, 62(5), 600-610.
  2.   Yepez D, Grandes XA, Talanki Manjunatha R, Habib S, Sangaraju SL. Fibromyalgia and Depression: A Literature Review of Their Shared Aspects. Cureus. 2022 May 11;14(5):e24909. doi: 10.7759/cureus.24909. PMID: 35698706; PMCID: PMC9187156.
  3.   Veltri A, Scarpellini P, Piccinni A, Conversano C, Giacomelli C, Bombardieri S, Bazzichi L, Dell’Osso L. Methodological approach to depressive symptoms in fibromyalgia patients. Clin Exp Rheumatol. 2012 Nov-Dec;30(6 Suppl 74):136-42. Epub 2012 Dec 14. PMID: 23261013.
  1.   Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006 Aug;67(8):1219-25. doi: 10.4088/jcp.v67n0807. PMID: 16965199.
  1.   Häuser W, Sarzi-Puttini P, Fitzcharles MA. Fibromyalgia syndrome: under-, over- and misdiagnosis. Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):90-97. Epub 2019 Feb 8. PMID: 30747096.
  1.   Lesley M. Arnold, Bill H. McCarberg, Andrew G. Clair, Ed Whalen, Neal Thomas, Anamaria Jorga, Lynne Pauer, Richard Vissing & Peter W. Park (2017) Dose–response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia, Postgraduate Medicine, 129:8, 921-933, DOI: 10.1080/00325481.2017.1384691
  1.   Izquierdo-Alventosa R, Inglés M, Cortés-Amador S, Gimeno-Mallench L, Sempere-Rubio N, Serra-Añó P. Effectiveness of High-Frequency Transcranial Magnetic Stimulation and Physical Exercise in Women With Fibromyalgia: A Randomized Controlled Trial. Phys Ther. 2021 Oct 1;101(10):pzab159. doi: 10.1093/ptj/pzab159. PMID: 34216139.
  1.   Alaa Mhalla, Sophie Baudic, Daniel Ciampi de Andrade, Michele Gautron, Serge Perrot, Manoel Jacobson Teixeira, Nadine Attal, Didier Bouhassira, Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia, PAIN®, Volume 152, Issue 7,2011,Pages 1478-1485,ISSN 0304-3959, https://doi.org/10.1016/j.pain.2011.01.034.
DIGITAL MARKETING BY ALLEVI8 MARKETING